Novelix Pharmaceuticals Ltd

TRIMURTHI

Watchlist

AI Mode

‌

Market Cap

₹ 59 Cr

P/E

—

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

REASONABLE

Growth

STABLE

Profitability

LOW MARGIN

Technicals

Bullish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Trimurthi Limited, originally a financial and securities company, transitioned into pharmaceuticals and drugs, marking significant industry diversification.

The company operates pharmacy retail outlets in Hyderabad and has expanded its operations in West Bengal and Assam, indicating a strategic geographic expansion in India.

Trimurthi Limited has also commenced operations in the food industry through a wholly-owned subsidiary, signaling diversification beyond pharmaceuticals.

The company received ISO 9001:2008 certification, demonstrating a commitment to quality in its pharmaceutical marketing and distribution processes.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

59 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

3.2

52W High

70.16

52W Low

24.15

Sales CAGR

-7.09%

231.51%

97.11%

10Y

47.49%

Profit CAGR

46.01%

—

-2.28%

10Y

-1.66%

ROE

TTM

-30.18%

0.11%

-9.96%

10Y

-3.75%

ROCE

TTM

-32.45%

0.27%

-9.88%

10Y

-3.58%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
RAJNISH	0.66	66 Cr	—	0.60	0.00	-0.10	0.05	-0.09
PHRMASI	94.42	64 Cr	82.82	9.92	0.00	7.28	7.84	1.76
ONYX	35.00	63 Cr	15.02	1.14	0.00	1.95	4.14	1.16
WELCURE	0.48	59 Cr	1.71	0.44	0.00	25.60	17.53	5.43
TRIMURTHI	61.09	59 Cr	—	3.24	0.00	-30.18	-32.45	-30.18
VRL	180.00	57 Cr	12.66	1.47	1.11	11.58	14.72	9.41
LASA	9.47	47 Cr	94.30	0.84	0.00	0.87	-11.71	-50.52

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022
Sales	2.05	2.48	2.19	2.51	4.35	2.46	1.11	0.69	1.36	1.24
Expenses	2.20	2.63	2.44	5.76	4.51	2.31	2.05	2.32	1.50	1.42
Operating Profit	-0.17	-0.17	-0.26	-3.26	-0.16	0.15	-0.94	-1.63	-0.14	-0.18
OPM %	-8.29	-6.85	-11.87	-129.88	-3.68	6.10	-84.68	-236.23	-10.29	-14.52
Other Income	0.12	0.07	0.11	0.03	0.17	0.33	0.03	0.12	0.08	0.05
Interest	0.02	0.02	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.05	0.03	0.08	0.06	0.05	0.04	0.04	-0.03	0.02	0.02
Profit Before Tax	-0.10	-0.13	-0.23	-3.29	-0.04	0.44	-0.95	-1.48	-0.09	-0.15
Tax %	10.00	-23.08	0.00	0.00	-75.00	20.45	22.11	-6.08	0.00	0.00
Net Profit	-0.09	-0.15	-0.23	-3.29	-0.07	0.35	-0.74	-1.57	-0.09	-0.15
EPS in Rs	-0.06	-0.11	-0.13	-2.03	-0.09	0.20	-0.39	-0.84	-0.06	-0.10

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Sales	5.96	5.77	6.35	5.72	9.19	11	9.89	10	9.24	8.61
Expenses	5.14	4.86	5.67	5.17	8.92	11	11	11	13	11
Operating Profit	0.81	0.90	0.68	0.55	0.22	-0.17	-0.86	-0.62	-3.86	-2.57
OPM %	13.57	15.69	10.67	9.63	2.35	-1.58	-8.73	-6.10	-41.79	-29.89
Other Income	0.01	0.02	0.00	0.13	0.17	0.21	0.95	0.60	0.32	0.64
Interest	0.01	0.01	0.00	0.00	0.05	0.16	0.13	0.11	0.06	0.00
Depreciation	0.27	0.29	0.41	0.35	0.19	0.24	0.21	0.19	0.21	0.10
Profit Before Tax	0.55	0.64	0.27	0.33	0.19	-0.20	-0.12	-0.21	-3.75	-2.03
Tax %	31.04	31.73	47.71	33.61	82.75	-71.70	-19.23	-20.53	-0.37	0.38
Net Profit	0.38	0.43	0.14	0.13	0.03	-0.35	-0.15	-0.26	-3.76	-2.03
EPS in Rs	—	-1.11	0.23	0.04	-0.01	—	-0.15	-0.17	-2.32	-1.12
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Equity Capital	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10
Reserves	2.93	3.37	3.33	3.45	3.44	3.07	2.82	2.50	-1.24	-0.70
Borrowings	0.04	0.01	0.00	0.00	0.96	0.98	0.93	0.77	0.00	0.13
Other Liabilities	0.47	0.73	1.08	1.18	1.25	1.44	1.49	2.35	2.71	1.20
Total Liabilities	12	12	13	13	14	14	13	14	9.57	8.74
Fixed Assets	1.22	1.17	0.75	0.70	2.10	2.17	1.92	1.83	1,653	0.47
CWIP	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.63	0.49	0.30	0.39	0.42
Other Assets	10	11	12	12	12	11	11	12	-1,644	7.85
Total Assets	12	12	13	13	14	14	13	14	9.57	8.74

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Cash from Operating Activity	-3.45	-0.03	-0.84	2.05	-1.82	0.37	-0.53	0.63	1.59	1.59
Cash from Investing Activity	1.06	0.80	-0.25	-1.06	0.21	-0.64	0.43	0.45	0.14	-0.76
Cash from Financing Activity	2.41	0.19	-0.01	0.22	0.77	0.02	-0.05	-0.16	-0.77	0.00
Net Cash Flow	0.01	0.96	-1.11	1.22	-0.84	-0.24	-0.15	0.92	0.96	0.83

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Nov 2025
Promoters	66.92%	66.92%	66.92%	66.92%	66.92%	66.54%	66.56%	66.56%	66.56%	52.75%	53.33%	54.82%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	33.08%	33.08%	33.08%	33.08%	33.08%	33.46%	33.44%	33.44%	33.44%	47.25%	46.67%	45.18%
Total Shareholders	2,414	2,391	2,389	2,621	2,635	2,569	2,533	2,502	2,484	2,481	2,697	2,770

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Jul 03, 2025	Medo capital services private...	Bulk	Sell	43.29	0.54 Cr	1,25,000	1.25
Sep 17, 2024	Arun kumar bhangadia	Insider - Promoter	Disposal	10.00	1.54 Cr	15,42,200	15.5
Sep 17, 2024	Arvind kumar devansh bhangadi...	Insider - Promoter	Disposal	10.00	0.12 Cr	1,20,000	1.21
Sep 17, 2024	Gopikishan arun kumar bhangad...	Insider - Promoter	Disposal	10.00	0.11 Cr	1,05,000	1.06
Sep 17, 2024	Arun kumar bhangadia huf	Insider - Promoter	Disposal	10.00	0.39 Cr	3,87,000	3.89
Sep 17, 2024	Tdpl health care india llp	Insider - Promoter	Disposal	10.00	1.08 Cr	10,80,000	10.8
Sep 17, 2024	Aditya bhangadia	Insider - Promoter	Disposal	10.00	0.17 Cr	1,65,000	1.66
Sep 17, 2024	Ravikumar bhangadia	Insider - Promoter	Disposal	10.00	0.07 Cr	66,333	0.67
Sep 17, 2024	Jyothi bhangadia	Insider - Promoter	Disposal	10.00	0.06 Cr	58,000	0.58
Sep 17, 2024	Kiran bhangadia	Insider - Promoter	Disposal	10.00	1.35 Cr	13,49,500	13.56

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

General Meeting

1 day ago

Extra-Ordinary General Meeting Scheduled

Notice issued for an Extra-ordinary General Meeting of Novelix Pharmaceuticals on January 9, 2026, to consider the preferential issuance of equity shares.

Shareholder Meeting

5 days ago

Extraordinary General Meeting Scheduled for January 9, 2026

The company has announced an Extra Ordinary General Meeting set to take place on January 9, 2026, with details regarding e-voting eligibility and deadlines.

Preferential Allotment

5 days ago

Novelix Pharmaceuticals Plans Preferential Issue

The Board of Novelix Pharmaceuticals has approved the issuance of 25 lacs equity shares on a preferential basis to raise additional capital, subject to EGM approval.

Board Meeting Outcome

5 days ago

Board Meeting Outcomes: Equity Share Issuance

The Board of Directors approved the issuance of 2,500,000 equity shares on a preferential basis to raise capital, pending approval from shareholders and authorities.

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
RAJNISH	0.66	66 Cr	—	0.60	0.00	-0.10	0.05	-0.09
PHRMASI	94.42	64 Cr	82.82	9.92	0.00	7.28	7.84	1.76
ONYX	35.00	63 Cr	15.02	1.14	0.00	1.95	4.14	1.16
WELCURE	0.48	59 Cr	1.71	0.44	0.00	25.60	17.53	5.43
TRIMURTHI	61.09	59 Cr	—	3.24	0.00	-30.18	-32.45	-30.18
VRL	180.00	57 Cr	12.66	1.47	1.11	11.58	14.72	9.41
LASA	9.47	47 Cr	94.30	0.84	0.00	0.87	-11.71	-50.52

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022
Sales	2.05	2.48	2.19	2.51	4.35	2.46	1.11	0.69	1.36	1.24
Expenses	2.20	2.63	2.44	5.76	4.51	2.31	2.05	2.32	1.50	1.42
Operating Profit	-0.17	-0.17	-0.26	-3.26	-0.16	0.15	-0.94	-1.63	-0.14	-0.18
OPM %	-8.29	-6.85	-11.87	-129.88	-3.68	6.10	-84.68	-236.23	-10.29	-14.52
Other Income	0.12	0.07	0.11	0.03	0.17	0.33	0.03	0.12	0.08	0.05
Interest	0.02	0.02	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.05	0.03	0.08	0.06	0.05	0.04	0.04	-0.03	0.02	0.02
Profit Before Tax	-0.10	-0.13	-0.23	-3.29	-0.04	0.44	-0.95	-1.48	-0.09	-0.15
Tax %	10.00	-23.08	0.00	0.00	-75.00	20.45	22.11	-6.08	0.00	0.00
Net Profit	-0.09	-0.15	-0.23	-3.29	-0.07	0.35	-0.74	-1.57	-0.09	-0.15
EPS in Rs	-0.06	-0.11	-0.13	-2.03	-0.09	0.20	-0.39	-0.84	-0.06	-0.10

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Sales	5.96	5.77	6.35	5.72	9.19	11	9.89	10	9.24	8.61
Expenses	5.14	4.86	5.67	5.17	8.92	11	11	11	13	11
Operating Profit	0.81	0.90	0.68	0.55	0.22	-0.17	-0.86	-0.62	-3.86	-2.57
OPM %	13.57	15.69	10.67	9.63	2.35	-1.58	-8.73	-6.10	-41.79	-29.89
Other Income	0.01	0.02	0.00	0.13	0.17	0.21	0.95	0.60	0.32	0.64
Interest	0.01	0.01	0.00	0.00	0.05	0.16	0.13	0.11	0.06	0.00
Depreciation	0.27	0.29	0.41	0.35	0.19	0.24	0.21	0.19	0.21	0.10
Profit Before Tax	0.55	0.64	0.27	0.33	0.19	-0.20	-0.12	-0.21	-3.75	-2.03
Tax %	31.04	31.73	47.71	33.61	82.75	-71.70	-19.23	-20.53	-0.37	0.38
Net Profit	0.38	0.43	0.14	0.13	0.03	-0.35	-0.15	-0.26	-3.76	-2.03
EPS in Rs	—	-1.11	0.23	0.04	-0.01	—	-0.15	-0.17	-2.32	-1.12
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Equity Capital	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10
Reserves	2.93	3.37	3.33	3.45	3.44	3.07	2.82	2.50	-1.24	-0.70
Borrowings	0.04	0.01	0.00	0.00	0.96	0.98	0.93	0.77	0.00	0.13
Other Liabilities	0.47	0.73	1.08	1.18	1.25	1.44	1.49	2.35	2.71	1.20
Total Liabilities	12	12	13	13	14	14	13	14	9.57	8.74
Fixed Assets	1.22	1.17	0.75	0.70	2.10	2.17	1.92	1.83	1,653	0.47
CWIP	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.63	0.49	0.30	0.39	0.42
Other Assets	10	11	12	12	12	11	11	12	-1,644	7.85
Total Assets	12	12	13	13	14	14	13	14	9.57	8.74

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Cash from Operating Activity	-3.45	-0.03	-0.84	2.05	-1.82	0.37	-0.53	0.63	1.59	1.59
Cash from Investing Activity	1.06	0.80	-0.25	-1.06	0.21	-0.64	0.43	0.45	0.14	-0.76
Cash from Financing Activity	2.41	0.19	-0.01	0.22	0.77	0.02	-0.05	-0.16	-0.77	0.00
Net Cash Flow	0.01	0.96	-1.11	1.22	-0.84	-0.24	-0.15	0.92	0.96	0.83

Overview

Detailed Summary

Trimurthi Limited, originally a financial and securities company, transitioned into pharmaceuticals and drugs, marking significant industry diversification.

The company operates pharmacy retail outlets in Hyderabad and has expanded its operations in West Bengal and Assam, indicating a strategic geographic expansion in India.

Trimurthi Limited has also commenced operations in the food industry through a wholly-owned subsidiary, signaling diversification beyond pharmaceuticals.

The company received ISO 9001:2008 certification, demonstrating a commitment to quality in its pharmaceutical marketing and distribution processes.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

59 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

3.2

52W High

70.16

52W Low

24.15

Sales CAGR

-7.09%

231.51%

97.11%

10Y

47.49%

Profit CAGR

46.01%

—

-2.28%

10Y

-1.66%

ROE

TTM

-30.18%

0.11%

-9.96%

10Y

-3.75%

ROCE

TTM

-32.45%

0.27%

-9.88%

10Y

-3.58%